Inventor · disambiguated record
Dean Falb
Also filed as: FALB DEAN · FALB DEAN A
43 granted patents·30 pending applications·1,018 citations·filing 1995–2023
98Inventor score
Files withSYNLOGIC OPERATING CO INC30MILLENNIUM PHARM INC24SYNLOGIC INC10BRIGHAM & WOMENS HOSPITAL2KROP JULIE1
Top patents by PatentIndex Score
73 records- 0198US6124433ACompositions and methods for treatment and diagnosis of cardiovascular diseaseMILLENNIUM PHARM INC·Filed 1997·Granted Sep 26, 2000·249 cites·5 claims
- 0296US10273489B2Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrierSYNLOGIC OPERATING CO INC·Filed 2016·Granted Apr 30, 2019·12 cites·6 claims
- 0396US9688967B2Bacteria engineered to treat diseases associated with hyperammonemiaSYNLOGIC INC·Filed 2016·Granted Jun 27, 2017·36 cites·20 claims
- 0496US6156500AMethods for the treatment and diagnosis of cardiovascular diseaseMILLENNIUM PHARM INC·Filed 1995·Granted Dec 5, 2000·212 cites·41 claims
- 0595US9889164B2Bacteria engineered to treat a disease or disorderSYNLOGIC INC·Filed 2016·Granted Feb 13, 2018·27 cites·20 claims
- 0695US9487764B2Bacteria engineered to treat diseases associated with hyperammonemiaSYNLOGIC INC·Filed 2015·Granted Nov 8, 2016·31 cites·18 claims
- 0794US11291693B2Bacteria engineered to treat metabolic diseasesSYNLOGIC OPERATING CO INC·Filed 2016·Granted Apr 5, 2022·9 cites·19 claims
- 0894US10933102B2Bacteria engineered to treat a disease or disorderSYNLOGIC OPERATING CO INC·Filed 2017·Granted Mar 2, 2021·7 cites·22 claims
- 0994US10610546B2Bacteria engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2016·Granted Apr 7, 2020·7 cites·8 claims
- 1093US11471494B2Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2018·Granted Oct 18, 2022·7 cites·10 claims
- 1192US11060073B2Bacteria engineered to treat diseases associated with hyperammonemiaSYNLOGIC OPERATING CO INC·Filed 2017·Granted Jul 13, 2021·5 cites·38 claims
- 1291US11723932B2Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2017·Granted Aug 15, 2023·5 cites·7 claims
- 1391US6048709ACompositions and methods for the treatment and diagnosis of cardiovascular diseaseMILLENNIUM PHARM INC·Filed 1997·Granted Apr 11, 2000·65 cites·15 claims
- 1490US11618894B2Bacteria engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2016·Granted Apr 4, 2023·5 cites·33 claims
- 1590US5948639ATGF-β pathway genesMILLENNIUM PHARM INC·Filed 1997·Granted Sep 7, 1999·58 cites·17 claims
- 1689US10195234B2Bacteria engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2016·Granted Feb 5, 2019·6 cites·15 claims
- 1787US9943555B2Bacteria engineered to reduce hyperphenylalaninemiaSYNLOGIC INC·Filed 2016·Granted Apr 17, 2018·5 cites·14 claims
- 1885US11879123B2Bacteria for the treatment of disordersSYNLOGIC OPERATING CO INC·Filed 2018·Granted Jan 23, 2024·4 cites·24 claims
- 1985US6225084B1Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd534 as a targetMILLENNIUM PHARM INC·Filed 1997·Granted May 1, 2001·38 cites·30 claims
- 2085US6099823ACompositions and methods for the treatment and diagnosis of cardiovascular diseaseMILLENNIUM PHARM INC·Filed 1998·Granted Aug 8, 2000·57 cites·22 claims
- 2181US5834248ACompositions and methods using rchd534, a gene uregulated by shear stressMILLENNIUM PHARM INC·Filed 1995·Granted Nov 10, 1998·30 cites·17 claims
- 2280US5882925ACompositions and method for the treatment and diagnosis of cardiovascular disease using rchd502 as a targetMILLENNIUM PHARM INC·Filed 1996·Granted Mar 16, 1999·17 cites·22 claims
- 2377US6534641B2Compositions and methods for the treatment and diagnosis of cardiovascular diseaseMILLENNIUM PHARM INC·Filed 1997·Granted Mar 18, 2003·23 cites·21 claims
- 2475US6087477ACompositions and methods for the treatment and diagnosis of cardiovascular diseaseMILLENNIUM PHARM INC·Filed 1997·Granted Jul 11, 2000·21 cites·3 claims
- 2574US2024382536A1Bacteria engineered to treat a disease or disorderSYNLOGIC OPERATING CO INC·Filed 2023·Application pending·0 cites
- 2673US11845964B2Bacteria engineered to treat diseases associated with hyperammonemiaSYNLOGIC OPERATING CO INC·Filed 2020·Granted Dec 19, 2023·0 cites·20 claims
- 2773US2024076645A1Bacteria engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 2872US12409195B2Bacteria engineered to reduce hyperphenylalaninemiaSYNLOGIC OPERATING CO INC·Filed 2020·Granted Sep 9, 2025·0 cites·9 claims
- 2972US2021095297A1Bacteria Engineered to Treat Diseases that Benefit from Reduced Gut Inflammation and/or Tighten Gut Mucosal BarrierSYNLOGIC OPERATING CO INC·Filed 2020·Application pending·0 cites
- 3071US11896627B2Bacteria engineered to treat metabolic diseasesSYNLOGIC OPERATING CO INC·Filed 2022·Granted Feb 13, 2024·0 cites·22 claims
- 3171US5807708AConservin nucleic acid molecules and compositionsMILLENNIUM PHARM INC·Filed 1996·Granted Sep 15, 1998·31 cites·54 claims
- 3270US5849578ACompositions and methods for the treatment and diagnosis of cardiovascular using RCHD528 as a targetMILLENNIUM PHARM INC·Filed 1996·Granted Dec 15, 1998·12 cites·21 claims
- 3369US2023226122A1Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 3467US2018273956A1Bacteria Engineered to Treat Diseases that Benefit from Reduced Gut Inflammation and/or Tighten Gut Mucosal BarrierSYNLOGIC INC·Filed 2018·Application pending·0 cites
- 3567US2024110192A1Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrierSYNLOGIC OPERATING CO INC·Filed 2023·Application pending·0 cites
- 3666US11883439B2Bacteria engineered to treat a disease or disorderSYNLOGIC OPERATING CO INC·Filed 2020·Granted Jan 30, 2024·0 cites·17 claims
- 3765US11384359B2Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrierSYNLOGIC OPERATING CO INC·Filed 2016·Granted Jul 12, 2022·0 cites·18 claims
- 3865US6018025ACompositions and methods for the treatment and diagnosis of cardiovascular disease using rchd528 as a targetMILLENIUM PHARM INC·Filed 1997·Granted Jan 25, 2000·11 cites·5 claims
- 3964US2023174939A1Novel anucleated cells as a source for treatment of platelet rich plasma dependent disordersSTELLULAR BIO INC·Filed 2022·Application pending·0 cites
- 4064US2024180974A1Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cellsSYNLOGIC OPERATING CO INC·Filed 2023·Application pending·0 cites
- 4163US5968770ACompositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a targetBRIGHAM & WOMENS HOSPITAL·Filed 1995·Granted Oct 19, 1999·9 cites·18 claims
- 4262US2022233609A1Bacteria engineered to treat disorders in which oxalate is detrimentalSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
- 4361US2016206666A1Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrierSYNLOGIC INC·Filed 2015·Application pending·0 cites
- 4460US2002178458A1Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd534 as a targetMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
- 4559US6054558ACompositions and methods for the treatment and diagnosis of cardiovascular disease using rchd534 as a targetMILLENNIUM PHARM INC·Filed 1997·Granted Apr 25, 2000·6 cites·3 claims
- 4659US2023332164A1Bacteria engineered to secrete active proteinsSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 4758US2004081992A1Compositions and methods for the treatment and diagnosis of cardiovascular diseaseMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 4856US2003188327A1Compositions and methods for the treatment and diagnosis of cardiovascular diseaseMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 4956US2022168362A1Bacteria engineered to treat disorders involving the catabolism of a branched chain amino acidSYNLOGIC OPERATING CO INC·Filed 2021·Application pending·0 cites
- 5056US2023043588A1Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrierSYNLOGIC OPERATING CO INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 73 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Dean Falb files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →